FI875102A0 - Analogiförfarande för framställning av ett såsom läkemedel användbart imidazolderivat - Google Patents

Analogiförfarande för framställning av ett såsom läkemedel användbart imidazolderivat

Info

Publication number
FI875102A0
FI875102A0 FI875102A FI875102A FI875102A0 FI 875102 A0 FI875102 A0 FI 875102A0 FI 875102 A FI875102 A FI 875102A FI 875102 A FI875102 A FI 875102A FI 875102 A0 FI875102 A0 FI 875102A0
Authority
FI
Finland
Prior art keywords
drug
preparing
imidazole derivative
analogous process
derivative useful
Prior art date
Application number
FI875102A
Other languages
English (en)
Finnish (fi)
Other versions
FI875102A (sv
FI91754C (sv
FI91754B (sv
Inventor
Yasushi Honma
Hajime Tamaki
Tetsuo Magaribuchi
Mine Takido
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI875102A0 publication Critical patent/FI875102A0/sv
Publication of FI875102A publication Critical patent/FI875102A/sv
Application granted granted Critical
Publication of FI91754B publication Critical patent/FI91754B/sv
Publication of FI91754C publication Critical patent/FI91754C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI875102A 1986-12-02 1987-11-18 Analogiförfarande för framställning av ett såsom läkemedel användbart imidazolderivat FI91754C (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP28751286 1986-12-02
JP28751286 1986-12-02
JP8047587 1987-03-31
JP8047587 1987-03-31
JP21581387 1987-08-28
JP21581387 1987-08-28

Publications (4)

Publication Number Publication Date
FI875102A0 true FI875102A0 (sv) 1987-11-18
FI875102A FI875102A (sv) 1988-06-03
FI91754B FI91754B (sv) 1994-04-29
FI91754C FI91754C (sv) 1994-08-10

Family

ID=27303307

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875102A FI91754C (sv) 1986-12-02 1987-11-18 Analogiförfarande för framställning av ett såsom läkemedel användbart imidazolderivat

Country Status (15)

Country Link
US (3) US5002945A (sv)
EP (1) EP0270091B1 (sv)
JP (1) JPH064623B2 (sv)
KR (1) KR930004843B1 (sv)
CN (1) CN1020902C (sv)
AU (1) AU597446B2 (sv)
DE (1) DE3782621T2 (sv)
DK (1) DK631587A (sv)
ES (1) ES2044901T3 (sv)
FI (1) FI91754C (sv)
FR (1) FR2607502B1 (sv)
GR (1) GR3006257T3 (sv)
HU (2) HU204812B (sv)
IL (1) IL84554A (sv)
TW (1) TW203048B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
JP2614756B2 (ja) * 1988-08-10 1997-05-28 日本ケミファ株式会社 イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
MY106533A (en) * 1990-02-20 1995-06-30 Sumitomo Chemical Co A 4-tert.-butyl imidazole derivative and its production and use.
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
CA2036148A1 (en) * 1990-06-29 1991-12-30 Hiroki Tomioka A 1-phenylimidazole derivative and its production and use
MY110439A (en) * 1991-02-07 1998-05-30 Ishihara Sangyo Kaisha N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
US5252590A (en) * 1991-06-28 1993-10-12 Sumitomo Chemical Company, Limited 1-pyridylimidazole derivative
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
DE19541146A1 (de) * 1995-10-25 1997-04-30 Schering Ag Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
US7880009B2 (en) * 2004-05-26 2011-02-01 Eisai R&D Management Co., Ltd. Cinnamide compound
JPWO2006038738A1 (ja) * 2004-10-08 2008-05-15 武田薬品工業株式会社 受容体機能調節剤
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
PE20081791A1 (es) 2007-02-28 2009-02-07 Eisai Randd Man Co Ltd Dos derivados ciclicos de oxomorfolina
BRPI0815773A2 (pt) 2007-08-31 2019-09-24 Eisai R&D Man Co Ltd composto, e, medicamento.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (sv) * 1968-10-21 1971-06-03
IN148930B (sv) * 1977-09-19 1981-07-25 Hoffmann La Roche
EP0004648B1 (de) * 1978-04-11 1982-08-25 Ciba-Geigy Ag Neue Mercaptoimidazolderivate, Verfahren zu deren Herstellung, Mercaptoimidazolderivate zur Behandlung entzündlicher Erkrankungen und diese enthaltende pharmazeutische Präparate
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
ATE25521T1 (de) * 1982-12-20 1987-03-15 Merck & Co Inc 5-(amino oder substituierte amino)-imidazole.
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
FI833794A0 (fi) * 1983-10-18 1983-10-18 Farmos Oy Substituerade 2-merkapto-imidazoler
GB8417171D0 (en) * 1984-07-05 1984-08-08 Beecham Group Plc Compounds
CA1341314C (en) * 1984-07-06 2001-11-06 David Cox Derivatives of benzimidazole, benzothiazole and benzoxazole
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
US4591377A (en) * 1985-09-10 1986-05-27 Stauffer Chemical Company Herbicidal esters of 2-bromo-4-methylimidazole-5-carboxylic acid
IL82401A0 (en) * 1986-05-06 1987-11-30 Merrell Dow Pharma Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them
JPH0674273B2 (ja) * 1986-06-19 1994-09-21 日産化学工業株式会社 イミダゾ−ルスルホンアミド誘導体、製法および除草剤

Also Published As

Publication number Publication date
TW203048B (sv) 1993-04-01
KR880007477A (ko) 1988-08-27
US5053417A (en) 1991-10-01
GR3006257T3 (sv) 1993-06-21
HU201751B (en) 1990-12-28
KR930004843B1 (ko) 1993-06-09
FI875102A (sv) 1988-06-03
IL84554A (en) 1992-03-29
US4996217A (en) 1991-02-26
FR2607502B1 (fr) 1990-01-19
FI91754C (sv) 1994-08-10
JPH064623B2 (ja) 1994-01-19
ES2044901T3 (es) 1994-01-16
HU905023D0 (en) 1991-01-28
FR2607502A1 (fr) 1988-06-03
DE3782621D1 (de) 1992-12-17
AU8181287A (en) 1988-06-02
HUT49128A (en) 1989-08-28
JPH01131175A (ja) 1989-05-24
DK631587D0 (da) 1987-12-01
EP0270091A1 (en) 1988-06-08
EP0270091B1 (en) 1992-11-11
DK631587A (da) 1988-06-03
US5002945A (en) 1991-03-26
IL84554A0 (en) 1988-04-29
CN1020902C (zh) 1993-05-26
CN87108111A (zh) 1988-09-28
AU597446B2 (en) 1990-05-31
HU204812B (en) 1992-02-28
FI91754B (sv) 1994-04-29
DE3782621T2 (de) 1993-04-22

Similar Documents

Publication Publication Date Title
FI895555A0 (sv) Förfarande för framställning av ett läkemedelsavgivande system
FI96029B (sv) Analogiförfarande för framställning av ett som läkemedel användbart pyridinderivat
FI20000084A (sv) Förfarande för framställning av en antifungal farmaceutisk komposition
FI894342A0 (sv) Förfarande för framställning av en cyklosporin innehållande farmaceutisk sammansättning
FI875102A0 (sv) Analogiförfarande för framställning av ett såsom läkemedel användbart imidazolderivat
PT86866A (pt) Process for preparing piperazinyl-heterocyclic compounds
FI934869A0 (sv) Förfarande för framställning av ett ämne för sänkning av serumets höga kolesterolnivå
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
FI98192B (sv) Förfarande för framställning av en näringskomposition
FI102517B1 (sv) Förfarande för framställning av ett terapeutiskt användbart immunokonjugat
KR850002745A (ko) 삼-치환 이미다졸 유도체의 제조방법
FI101676B1 (sv) Förbättrat förfarande för framställning av en stabil mikrosfärkomposition
FI882858A0 (sv) Förfarande för framställning av drivladdningspulver
FI102391B1 (sv) Förfarande för framställning av en cellulosaformkropp
FI880436A (sv) Förfarande för behandling av ett fluorescerande ämne
FI97230B (sv) Förfarande för framställning av terapeutiskt användbara 7-oxabicykloheptylsubstituerade heterocykliska amidprostaglandinderivat
FI860101A (sv) Analogiförfarande för framställning av ett nytt läkemedel
FI884984A (sv) Förfarande för framställning av målderivat av metyltritioföreningar
FI97807B (sv) Förfarande för framställning av en ej-racemisk form av furo/3,4-c/pyridinderivat
FI913554A (sv) Förfarande för framställning av en stabiliserad farmaceutisk komposition
FI99080B (sv) Förfarande för framställning av emulsioner för parenteral administrering
PT87564A (pt) Process for preparing substituted vinylcephalosporins useful as medicaments
FI881158A (sv) Förfarande för framställning av ett terapeutiskt användbart immunoglobulinkonjugat
FI885652A0 (sv) Förfarande för framställning av en olefinpolymer
FI885950A (sv) Förfarande för framställning av ett vattenlösligt katjoniskt polymer

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: TANABE SEIYAKU CO., LTD.